Teza Capital Management LLC Vanda Pharmaceuticals Inc. Transaction History

Teza Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$9.32 - $12.02 $126,230 - $162,798	-13,544 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$9.66 - $12.02 $21,252 - $26,444	-2,200 Reduced 13.97%	13,544 $155,000
Q1 2020 May 11, 2020	SELL	$7.5 - $16.8 $69,495 - $155,668	-9,266 Reduced 37.05%	15,744 $163,000
Q4 2019 Feb 12, 2020	SELL	$12.38 - $17.47 $98,421 - $138,886	-7,950 Reduced 24.12%	25,010 $410,000
Q3 2019 Nov 12, 2019	BUY	$12.27 - $15.79 $404,419 - $520,438	32,960 New	32,960 $438,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $268M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.